Why the study?
Does high-degree atrioventricular block affect the incidence of no-reflow and mortality in patients with STEMI?
Cohort (n=1,217)
No
Does high-degree atrioventricular block affect the incidence of no-reflow and mortality in patients with STEMI?
This study aims to investigate the mechanistic link between high-degree AV block, the no-reflow phenomenon, and mortality in patients presenting with STEMI.
Answers are grounded in this paper and cite their sources.
High-degree AV block flags higher no-reflow and mortality risk in STEMI; leaves open whether targeted strategies improve outcomes.
Although it has been established that high-degree atrioventricular block (HAVB) is associated with mortality in the course of ST segment elevation myocardial infarction (STEMI), the mechanisms by which this AV block cause mortality are not yet fully understood. In this study we aimed: (i) to investigate the relationship between HAVB and no-reflow, which has been repeatedly shown to be associated with both short-and long-term mortality; (ii) to determine the effect of both HAVB and no-reflow on in-hospital and long-term mortality.
No takes yet. Share an insight, caveat, or question.
Çağdaş et al. (2018) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=1,217). High-degree atrioventricular block (HAVB) vs. No high-degree atrioventricular block was evaluated on No-reflow phenomenon (OR 3.127, 95% CI 1.215-9.056, p=0.006).
Synapse has enriched 10 related papers. Consider them for comparative context: